Sun Pharma
BSE: 524715
|
NSE: SUNPHARMA
Sun Pharma
(CIN: L24230GJ1993PLC019050)
operates in the Pharmaceuticals industry and has been listed in the stock market since 19th Dec 1994.
It currents trades on NSE with symbol SUNPHARMA and on BSE with scrip code 524715.
The registered office of the company is SPARC, Tandalja,Vadodara,Gujarat,390012.
The management team of Sun Pharma is led by Mr. Israel Makov who is the Non-Executive - Non Independent Director-Chairperson. Other members of the management team consist of Mr. Dilip S. Shanghvi (Designation:Executive Director-MD), C S Muralidharan (Designation:Chief Financial Officer), Mr. Sudhir V Valia (Designation:Non-Executive - Non Independent Director), Mr. Sailesh T. Desai (Designation:Executive Director), Mr. Kalayanasundaram Subramanian (Designation:Executive Director), Ms. Rekha Sethi (Designation:Non-Executive - Independent Director), Mr. Vivek Chaand Sehgal (Designation:Non-Executive - Independent Director), Mr. Gautam Bhailal Doshi (Designation:Non-Executive - Independent Director), Ashok I Bhuta (Designation:Compliance Officer), Sunil Ajmera (Designation:Company Secretary), .
The price and other financial information of Sun Pharma is as below -
The registered office of the company is SPARC, Tandalja,Vadodara,Gujarat,390012.
The management team of Sun Pharma is led by Mr. Israel Makov who is the Non-Executive - Non Independent Director-Chairperson. Other members of the management team consist of Mr. Dilip S. Shanghvi (Designation:Executive Director-MD), C S Muralidharan (Designation:Chief Financial Officer), Mr. Sudhir V Valia (Designation:Non-Executive - Non Independent Director), Mr. Sailesh T. Desai (Designation:Executive Director), Mr. Kalayanasundaram Subramanian (Designation:Executive Director), Ms. Rekha Sethi (Designation:Non-Executive - Independent Director), Mr. Vivek Chaand Sehgal (Designation:Non-Executive - Independent Director), Mr. Gautam Bhailal Doshi (Designation:Non-Executive - Independent Director), Ashok I Bhuta (Designation:Compliance Officer), Sunil Ajmera (Designation:Company Secretary), .
The price and other financial information of Sun Pharma is as below -
Volume: 2,22,439.00
M. Cap: 1,19,881.00
P/E: 37.34
Prev. Close: 493.45
Day
52 Wk
Volume: 75,04,280.00
M. Cap: 1,19,881.00
P/E: 37.34
Prev. Close: 493.90
Day
52 Wk
Stock Price Chart
F&O Data
| Expiry Date | Open Price | High Price | Low Price | Prev Close | Last Price | Volume | Turnover Lacs | Underlying Value |
|---|---|---|---|---|---|---|---|---|
| 30-07-2020 | 495.35 | 502.95 | 493.00 | 494.80 | 499.10 | 7,653.00 | 53,463.86 | 498.35 |
| 27-08-2020 | 499.35 | 503.65 | 494.25 | 495.30 | 500.50 | 126.00 | 882.83 | 498.35 |
| 24-09-2020 | 498.65 | 502.00 | 497.80 | 496.10 | 502.00 | 3.00 | 20.98 | 498.35 |
| Calls | 30 Jul 2020 | Puts | ||||||
|---|---|---|---|---|---|---|---|---|
| OI (Delta OI) |
LTP (Change) |
Intrinsic Value | Time Value | Strike Price | Time Value | Intrinsic Value | LTP (Change) |
OI (Delta OI) |
| - |
- |
- | - | 300 | - | - | - |
- |
| - |
- |
- | - | 310 | - | - | - |
- |
| - |
- |
- | - | 320 | - | 0 | - |
1,400 (-) |
| - |
- |
- | - | 330 | - | - | - |
- |
| - |
- |
- | - | 340 | - | - | - |
- |
| 7,11,200 (-) |
- |
149.65 | - | 350 | 0.1 | 0 | 0.10 (-0.10) |
4,77,400 (-4,200.00) |
| - |
- |
- | - | 360 | - | 0 | - |
2,800 (-) |
| - |
- |
- | - | 370 | - | 0 | - |
1,400 (-) |
| - |
- |
- | - | 380 | - | 0 | - |
1,400 (-) |
| - |
- |
- | - | 390 | - | 0 | - |
1,400 (-) |
| 1,87,600 (+2,800.00) |
97.05 (-1.10) |
99.65 | -2.6 | 400 | 0.45 | 0 | 0.45 (-0.40) |
6,32,800 (+1,400.00) |
| 2,800 (-) |
- |
89.65 | - | 410 | 0.6 | 0 | 0.60 (-0.45) |
2,15,600 (-1,400.00) |
| 7,000 (-) |
- |
79.65 | - | 420 | 1 | 0 | 1.00 (-0.40) |
2,01,600 (+7,000.00) |
| 4,200 (-) |
- |
69.65 | - | 430 | 1.6 | 0 | 1.60 (-0.35) |
4,62,000 (-4,200.00) |
| 21,000 (-) |
- |
59.65 | - | 440 | 2.2 | 0 | 2.20 (-0.55) |
5,02,600 (-19,600.00) |
| 58,800 (-9,800.00) |
52.50 (+4.00) |
49.65 | 2.85 | 450 | 3 | 0 | 3.00 (-0.90) |
4,38,200 (-8,400.00) |
| 96,600 (-8,400.00) |
43.70 (+3.80) |
39.65 | 4.05 | 460 | 4.5 | 0 | 4.50 (-1.25) |
3,02,400 (-29,400.00) |
| 1,58,200 (-9,800.00) |
37.00 (+4.15) |
29.65 | 7.35 | 470 | 6.7 | 0 | 6.70 (-1.60) |
3,62,600 (+2,800.00) |
| 3,51,400 (-51,800.00) |
29.00 (+2.35) |
19.65 | 9.35 | 480 | 9.55 | 0 | 9.55 (-2.20) |
4,57,800 (+14,000.00) |
| 3,08,000 (-85,400.00) |
22.70 (+1.65) |
9.65 | 13.05 | 490 | 13.7 | 0 | 13.70 (-2.45) |
3,09,400 (+51,800.00) |
| 21,91,000 (-3,19,200.00) |
17.80 (+1.30) |
0 | 17.8 | 500 | 18.15 | 0.35 | 18.50 (-3.05) |
2,88,400 (+89,600.00) |
| 5,23,600 (+93,800.00) |
13.90 (+1.25) |
0 | 13.9 | 510 | 14.55 | 10.35 | 24.90 (-2.80) |
33,600 (+16,800.00) |
| 15,94,600 (-4,200.00) |
10.60 (+0.95) |
0 | 10.6 | 520 | 10.65 | 20.35 | 31.00 (-4.00) |
14,000 (-4,200.00) |
| 5,69,800 (+42,000.00) |
8.15 (+0.70) |
0 | 8.15 | 530 | 9.1 | 30.35 | 39.45 (-3.60) |
6,30,000 (-1,400.00) |
| 5,37,600 (+63,000.00) |
6.30 (+0.45) |
0 | 6.3 | 540 | 4.15 | 40.35 | 44.50 (-6.45) |
4,200 (-) |
| 14,78,400 (+67,200.00) |
4.85 (+0.35) |
0 | 4.85 | 550 | 5.95 | 50.35 | 56.30 (-1.20) |
5,69,800 (+2,800.00) |
| 2,18,400 (+12,600.00) |
3.75 (+0.35) |
0 | 3.75 | 560 | - | 60.35 | - |
1,400 (-) |
| 1,51,200 (+4,200.00) |
2.85 (+0.10) |
0 | 2.85 | 570 | - | 70.35 | - |
5,600 (-) |
| 3,80,800 (+7,000.00) |
2.35 (+0.05) |
0 | 2.35 | 580 | - | 80.35 | - |
5,600 (-) |
| 3,22,000 (+14,000.00) |
1.60 (-) |
0 | 1.6 | 590 | -0.35 | 90.35 | 90.00 (-7.10) |
21,000 (-) |
Shareholding Pattern
| Category | No. of shares | Percent(%) |
|---|---|---|
| Promoters | 1,31,21,34,535 | 54.69 |
| Foreign Institutions | 30,73,13,174 | 12.81 |
| NBFC and Mutual Funds | 25,84,65,884 | 10.77 |
| Central Government | 6,430 | 0.00 |
| Others | 12,57,42,673 | 5.24 |
| General Public | 18,47,96,085 | 7.70 |
| Financial Institutions | 21,08,76,189 | 8.79 |
| Total | 2,39,93,34,970 | 100 |
NSE Trade Data
| VWAP | 498.43 |
| Face Value | 1.00 |
| Traded Volume (shares) | 75,04,401.00 |
| Traded Value (lacs) | 37,404.19 |
| Free Float Market Cap (Crs) | 53,326.42 |
| 52 week high | 512.70 |
| 52 week low | 312.00 |
| Lower Price Band | 444.55 |
| Upper Price Band | 543.25 |
Security-wise Delivery Position
| Quantity Traded | 62,57,218.00 |
| Deliverable Quantity (gross across client level) | 19,61,939.00 |
| % of Deliverable Quantity to Traded Quantity | 31.35 % |
Value at Risk (VaR in %)
| Security VaR | 15.52 |
| Index VaR | - |
| VAR Margin | 15.52 |
| Extreme Loss Rate | 3.50 |
| Adhoc Margin | 4.96 |
| Applicable Margin Rate | 23.98 |
Financial Data
Consolidated
| Figures in crore | 2019 | 2018 | 2017 |
|---|---|---|---|
| Net Sales | 29,065.91 | 26,489.46 | 31,578.44 |
| Operating Profit | 6,118.70 | 5,496.39 | 10,712.42 |
| Other Income | 1,025.49 | 838.76 | 623.15 |
| Interest | 555.25 | 517.57 | 399.80 |
| Depreciation | 1,753.25 | 1,499.84 | 1,264.75 |
| Profit Before Tax | 3,810.20 | 3,478.98 | 9,047.87 |
| Tax | 600.88 | 911.04 | 1,211.57 |
| Profit After Tax | 3,209.32 | 2,567.94 | 7,836.30 |
| Share Capital | 239.93 | 239.93 | 239.93 |
| Reserves | 41,169.13 | 38,074.18 | 36,399.74 |
| Net Worth | 41,409.06 | 38,314.11 | 36,639.67 |
| Loans | 11,519.06 | 10,847.98 | 11,173.59 |
| Gross Block | 31,687.04 | 26,948.81 | 24,466.42 |
| Investments | 7,902.53 | 7,142.87 | 1,191.88 |
| Cash | 7,275.60 | 9,929.38 | 15,140.84 |
| Debtors | 8,884.20 | 7,815.28 | 7,202.61 |
| Net Working Capital | 25,091.44 | 24,585.57 | 29,935.69 |
| Operating Profit Margin (%) | 21.05 | 20.75 | 33.92 |
| Net Profit Margin (%) | 11.04 | 9.69 | 24.82 |
| Earning Per Share (Rs) | 11.11 | 8.73 | 29.03 |
| Dividend (%) | 275.00 | 200.00 | 350.00 |
| Dividend Payout | 479.16 | 797.74 | 240.68 |
Standalone
| Figures in crore | 2019 | 2018 | 2017 |
|---|---|---|---|
| Net Sales | 10,303.21 | 8,982.49 | 7,683.96 |
| Operating Profit | 1,813.32 | 1,155.80 | 629.05 |
| Other Income | 1,271.44 | 1,128.04 | 515.08 |
| Interest | 540.92 | 388.31 | 223.57 |
| Depreciation | 552.95 | 487.24 | 422.28 |
| Profit Before Tax | 719.45 | 280.25 | -16.80 |
| Tax | -97.15 | -25.39 | 6.04 |
| Profit After Tax | 816.60 | 305.64 | -22.84 |
| Share Capital | 239.93 | 239.93 | 239.93 |
| Reserves | 22,603.68 | 22,082.68 | 20,772.54 |
| Net Worth | 22,843.61 | 22,322.61 | 21,012.47 |
| Loans | 6,612.83 | 7,230.10 | 7,180.12 |
| Gross Block | 7,461.34 | 6,572.66 | 4,988.08 |
| Investments | 17,904.11 | 18,355.26 | 19,333.30 |
| Cash | 340.77 | 155.27 | 170.28 |
| Debtors | 5,031.47 | 5,271.44 | 2,714.70 |
| Net Working Capital | 5,931.37 | 5,565.04 | 3,720.16 |
| Operating Profit Margin (%) | 17.60 | 12.87 | 8.19 |
| Net Profit Margin (%) | 7.93 | 3.40 | -0.30 |
| Earning Per Share (Rs) | 3.40 | 1.27 | 0.00 |
| Dividend (%) | 275.00 | 200.00 | 350.00 |
| Dividend Payout | 479.16 | 797.74 | 240.68 |
| Bonus History | Date | Ratio |
|---|---|
| 29 Jul 2013 | issue 1:1 |
Financial Data Graph
The peers of Sun Pharma are AUROPHARMA, DRREDDY and LUPIN. You can get more detailed information on those company by clicking on the respective names.
* The above data is collected from public sources and we do not guarantee the accuracy of the same.*
Popular Comments
No comment posted for this article.